Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease

被引：0
作者：
Jessica Kendrick
Michel B Chonchol
机构：
[1] J Kendrick is a first-year Nephrology Fellow and MB Chonchol is an Associate Professor of Medicine at the University of Colorado Health Sciences Center in Denver,
[2] CO,undefined
[3] USA.,undefined
来源：
Nature Clinical Practice Nephrology | 2008年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The severity and extent of cardiovascular complications in patients with chronic kidney disease is disproportionate to the number and severity of traditional risk factors, such as diabetes and hypertension. Could uremia-related factors—including anemia, microalbuminuria, inflammation, oxidative stress, and abnormalities in bone and mineral metabolism—account for this discrepancy? Authors from the University of Colorado Health Sciences Center weigh up the evidence from randomized controlled trials of interventions for these so-called 'nontraditional' risk factors.
引用
收藏
页码：672 / 681
页数：9
相关论文
共 100 条
[81]  
Block GA(2002)Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39 695-701
[82]  
Ganesh SK(2000)Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis N Engl J Med 342 1478-1483
[83]  
Kestenbaum B(2002)Clinical correlates and mortality impact of left ventricular hypertrophy among new ESRD patients in the United States Am J Kidney Dis 40 1202-1210
[84]  
Dhingra R(1998)Death risk factor analysis in primary hyperparathyroidism Eur J Clin Invest 28 1011-1018
[85]  
Tonelli M(2003)Parathyroid hormone and left ventricular hypertrophy Eur Heart J 24 2054-2060
[86]  
Raggi P(2000)Arterial stiffening and vascular calcifications in end-stage renal disease Nephrol Dial Transplant 15 1014-1021
[87]  
Goodman WG(2008)A 1-year randomized trial of calcium acetate vs sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study Am J Kidney Dis 51 952-965
[88]  
Stack AG(2007)Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients Kidney Int 71 438-441
[89]  
Saran R(2007)Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients Kidney Int 72 1130-1137
[90]  
Hedback G(2006)Beta blockers in the management of chronic kidney disease Kidney Int 70 1905-1913
12345678910